Akari Therapeutics, Plc Earnings Per Share (Diluted)
Akari Therapeutics, Plc (AKTX) reported Earnings Per Share (Diluted) of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- Akari Therapeutics, Plc earnings per share, diluted for the quarter ending 2026-06-30 was $0.00.
- Akari Therapeutics, Plc earnings per share, diluted for the quarter ending 2026-03-31 was $0.00.
- Akari Therapeutics, Plc earnings per share, diluted for the quarter ending 2025-12-31 was -$0.00.
- Akari Therapeutics, Plc earnings per share, diluted for the quarter ending 2025-09-30 was $0.00.
- Akari Therapeutics, Plc earnings per share, diluted for fiscal 2025 was $0.00.
- Akari Therapeutics, Plc earnings per share, diluted for fiscal 2024 was $0.00.
- Akari Therapeutics, Plc earnings per share, diluted for fiscal 2023 was $0.00.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-06-04 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-06-04 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.00 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2024-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-06-04 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-06-04 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-06-04 | $0.00 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2023-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-19 | -$0.00 derived: net income ÷ weighted average shares · filed 2024-11-19 | $0.00 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | -$0.29 8-K · filed 2024-09-06 | $0.00 10-Q · filed 2024-08-19 | -$0.63 8-K · filed 2024-09-06 | $0.00 6-K · filed 2023-09-29 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | -$0.74 8-K · filed 2024-09-06 | $0.00 20-F · filed 2023-05-01 | |||||
| 2022-06-30 | $0.00 6-K · filed 2022-09-27 | $0.00 6-K · filed 2023-09-29 | |||||
| 2021-12-31 | $0.00 20-F · filed 2023-05-01 | ||||||
| 2021-06-30 | $0.00 6-K · filed 2022-09-27 | $0.00 6-K · filed 2022-09-27 | |||||
| 2020-12-31 | -$0.01 20-F · filed 2023-05-01 | ||||||
| 2019-12-31 | -$0.01 20-F · filed 2022-05-16 | ||||||
| 2019-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-04-21 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-04-21 | |||||
| 2018-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-04-21 | ||||||
| 2018-06-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-08-29 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-08-29 | |||||
| 2017-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2020-03-31 | ||||||
| 2017-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-09-27 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-09-27 | |||||
| 2016-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-04-23 | ||||||
| 2016-06-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-08-10 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-08-10 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-07-18 | |||
| 2016-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-05-12 | $0.00 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-07-18 | |||
| 2015-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-07-18 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-07-18 | |||
| 2015-09-30 | -$0.06 derived: net income ÷ weighted average shares · filed 2015-11-23 | -$0.07 derived: net income ÷ weighted average shares · filed 2017-04-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2015-11-23 | -$0.09 derived: net income ÷ weighted average shares · filed 2017-04-14 | |||
| 2015-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-04-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-04-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-04-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-04-14 | |||
| 2015-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-05-12 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-03-31 | ||||
| 2014-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-03-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-03-31 | ||||
| 2014-09-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2015-11-23 | -$0.01 derived: net income ÷ weighted average shares · filed 2015-11-23 | |||||
| 2013-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2015-02-11 | ||||||
| 2012-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |